Volume 94, Issue 5, Pages (November 2018)

Slides:



Advertisements
Similar presentations
Review of Basic Principles of Chemistry, Amino Acids and Proteins Brian Kuhlman: The material presented here is available on the.
Advertisements

Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case–Control Study  Zhi-Peng.
Volume 79, Issue 1, Pages (January 2013)
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 2, Issue 6, Pages (June 2015)
Volume 77, Issue 9, Pages (May 2010)
Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic.
Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic.
Proteins.
David Craig, Mu Gao, Klaus Schulten, Viola Vogel  Structure 
Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical.
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Frederik Persson, Peter Rossing  Kidney International Supplements 
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Fig. 5-UN1  carbon Amino group Carboxyl group.
Volume 92, Issue 1, Pages (July 2017)
Volume 74, Issue 6, Pages (December 2018)
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial  Li Zhang,
Volume 11, Issue 10, Pages (October 2004)
Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia  Lan-Ping Xu, Zheng-Li Xu, Xiao-Hui Zhang, Huan.
Volume 84, Issue 1, Pages (July 2013)
Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor  Biao Huang, PhD,
Β-Hairpin Folding Mechanism of a Nine-Residue Peptide Revealed from Molecular Dynamics Simulations in Explicit Water  Xiongwu Wu, Bernard R. Brooks  Biophysical.
Chronic Kidney Disease in Diabetes
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 1, Pages (July 2011)
Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With.
John P. Middleton, Patrick H. Pun  Kidney International 
Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic.
Volume 84, Issue 2, Pages (August 2013)
Volume 72, Issue 10, Pages (November 2007)
Volume 92, Issue 1, Pages (July 2017)
Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian, Yan Yan, Ziyad Al-Aly 
Volume 84, Issue 5, Pages (November 2013)
Volume 79, Issue 5, Pages (March 2011)
Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity  Juan Zhao, Zhao Cui, Rui Yang,
Volume 70, Issue 11, Pages (December 2006)
Volume 95, Issue 2, Pages (February 2019)
Volume 87, Issue 4, Pages (April 2015)
Volume 85, Issue 6, Pages (June 2014)
Volume 76, Issue 10, Pages (November 2009)
Amino Acid Variants of HLA-DRB1 Confer Susceptibility to Dapsone Hypersensitivity Syndrome in Addition to HLA-B*13:01  Zhenhua Yue, Yonghu Sun, Chuan.
Positive Results of Serum Galactomannan Assays and Pulmonary Computed Tomography Predict the Higher Response Rate of Empirical Antifungal Therapy in.
Volume 70, Issue 12, Pages (December 2006)
Volume 7, Issue 4, Pages (October 1997)
Volume 54, Issue 5, Pages (June 2014)
Volume 72, Issue 12, Pages (December 2007)
The Effect of Intravenous Vitamin C Infusion on Periprocedural Myocardial Injury for Patients Undergoing Elective Percutaneous Coronary Intervention 
Volume 77, Issue 9, Pages (May 2010)
Methods for guideline development
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
Volume 76, Issue 8, Pages (October 2009)
David Craig, Mu Gao, Klaus Schulten, Viola Vogel  Structure 
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 85, Issue 5, Pages (May 2014)
Volume 76, Issue 6, Pages (September 2009)
Volume 83, Issue 3, Pages (March 2013)
Volume 80, Issue 10, Pages (November 2011)
Glucose transporter (GLUT1) allele (XbaI–) associated with nephropathy in non-insulin- dependent diabetes mellitus  Zhi-Hong Liu, Tian-Jun Guan, Zhao-Hong.
Volume 83, Issue 3, Pages (March 2013)
Membranous nephropathy: recent travels and new roads ahead
Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia,
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Prediction in idiopathic membranous nephropathy
Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs.
Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome–Positive Acute.
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Volume 94, Issue 5, Pages 974-982 (November 2018) HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy  Huai-yu Wang, Zhao Cui, Li-jun Xie, Li-jie Zhang, Zhi-Yong Pei, Fang-jin Chen, Zhen Qu, Jing Huang, Yi-miao Zhang, Xin Wang, Fang Wang, Li-qiang Meng, Xu-yang Cheng, Gang Liu, Xu-jie Zhou, Hong Zhang, Hanna Debiec, Pierre Ronco, Ming-hui Zhao  Kidney International  Volume 94, Issue 5, Pages 974-982 (November 2018) DOI: 10.1016/j.kint.2018.06.005 Copyright © 2018 International Society of Nephrology Terms and Conditions

Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 1 Flowchart of the main findings of the genotype–phenotype analysis in primary membranous nephropathy (pMN) patients. eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; PLA2R, M-type phospholipase A2 receptor. Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 2 Comparison of chronic kidney disease (CKD) stages in primary membranous nephropathy patients with versus without the human leukocyte antigen class II allele DRB1*1502. Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 3 Analysis of gene–gene interaction: odds ratios for anti-M-type phospholipase A2 receptor (PLA2R) antibody levels, for human leukocyte antigen DRB1*1502 and DRB1*0301 combinations (a) and DRB1*1502 and DRB1*1501 combinations (b). The combination of DRB1*0301 and DRB1*1502 confers a 5.45-fold greater risk of higher anti-PLA2R antibody level, using both negative alleles as a reference (P = 0.049). No gene–gene interaction was found with the combination of DRB1*1501 and DRB1*1502 (P = 0.150). Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 4 Kaplan–Meier renal survival curves (end-stage renal disease) in primary membranous nephropathy patients. Patients with human leukocyte antigen DRB1*1502 had worse kidney outcomes during follow-up (P = 0.013). Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 5 Structure models of pocket 1 of DRB1*1501 and DRB1*1502. Sheet and spiral structures are shown by purple and cyan, respectively. Key amino acids are highligted in green. Oxygen and nitrogen are shown in red and dark blue, respectively. In pocket 1 of the DRB1*1501 molecule, the side chain of valine on position 86 is isopropyl; the greater steric hindrance of this side chain leads to a smaller pocket (a). In pocket 1 of the DRB1*1502 molecule, the side chain of glycine on position 86 is hydrogen; the lower level of steric hindrance of this side chain leads to a larger pocket (b). GLY, glycine; PHE, phenylalanine; VAL, valine. Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 6 Structure models of the DRB1*1502 molecule and the M-type phospholipase A2 receptor (PLA2R) CLTD4-FKVFHSEKV peptide. The peptide is shown by yellow. The DRB1*1502 molecule is shown by purple and blue. Overall structure of peptide CLTD4-FKVFHSEKV and the DRB1*1502 molecule (a). Pockets of the DRB1*1502 molecule are highlighted in green. Lysine679 of the peptide could be presented by pocket 4. The nitrogen of glutamine70 in pocket 4 could then form a hydrogen bond with the oxygen of lysine679 of the peptide. The distance between these 2 atoms is 3.9 Å (b). Lysine679 of the peptide could be presented by pocket 6 and pocket 7. The oxygen of tyrosine30 in pocket 6 could form a hydrogen bond with the hydrogen of lysine679 of the peptide. The distance between these 2 atoms is 2.9 Å. The oxygen of aspartic28 in pocket 7 could form a hydrogen bond with the nitrogen of lysine679 of the peptide. The distance between these 2 atoms is 2.5 Å (c). Phenylalanine678 of the peptide could be presented by pocket 9. The oxygen of tyrosine60 in pocket 9 could form a hydrogen bond with the nitrogen of phenylalanine678 of the peptide. The distance between these 2 atoms is 2.5 Å (d). ASP, aspartate; GLN, glycine; LYS, lysine; PHE, phenylalanine; TYR, tyrosine. Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure S1 Comparisons of serum anti- M-type phospholipase A2 receptor (PLA2R) antibody levels in primary membranous nephropathy (pMN) patients with versus without the following: human leukocyte antigen (HLA)-DRB1*0301 (A); DRB1*1502 (B); the combination of DRB1*1502 and DRB1*0301 (C); DRB1*0701 (D); DRB1*0201 (E); and DQB1*0202 (F). Kidney International 2018 94, 974-982DOI: (10.1016/j.kint.2018.06.005) Copyright © 2018 International Society of Nephrology Terms and Conditions